Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Retrofit for Energy and Environmental Performance (REEP) Program Act
Client: MEDICINES COMPANY · Firm: JOHN LAMPMANN
H.R. 1778
Retrofit for Energy and Environmental Performance (REEP) Program Act
Client: MEDICINES COMPANY · Firm: JOHN LAMPMANN
H.R. 1778
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MEDICINES COMPANY via JOHN LAMPMANN
2010 · fourth_quarter · 4T
HR 1778
Filing targets: HOUSE OF REPRESENTATIVES
MEDICINES COMPANY via JOHN LAMPMANN
2010 · third_quarter · Q3
Source: Senate LDA
Retrofit for Energy and Environmental Performance (REEP) Program Act
Client: MEDICINES COMPANY · Firm: JOHN LAMPMANN
HR 1778
Retrofit for Energy and Environmental Performance (REEP) Program Act
Client: MEDICINES COMPANY · Firm: JOHN LAMPMANN
H.R. 1778
Retrofit for Energy and Environmental Performance (REEP) Program Act
Client: MEDICINES COMPANY · Firm: JOHN LAMPMANN
H.R. 1778
Retrofit for Energy and Environmental Performance (REEP) Program Act
Client: MEDICINES COMPANY · Firm: JOHN LAMPMANN
H.R. 1778
Retrofit for Energy and Environmental Performance (REEP) Program Act
Client: MEDICINES COMPANY · Firm: JOHN LAMPMANN
H.R. 1778
Retrofit for Energy and Environmental Performance (REEP) Program Act
Client: MEDICINES COMPANY · Firm: JOHN LAMPMANN
H.R. 1778
Retrofit for Energy and Environmental Performance (REEP) Program Act
Client: MEDICINES COMPANY · Firm: JOHN LAMPMANN
H.R. 1778
To amend title 35, United States Code, to allow the Director of the United States Patent and Trademark Office to accept late filings in certain cases of unintentional delay.
Client: MEDICINES COMPANY · Firm: JOHN LAMPMANN
H.R. 1778, H.R. 6643
To amend title 35, United States Code, to allow the Director of the United States Patent and Trademark Office to accept late filings in certain cases of unintentional delay.
Client: MEDICINES COMPANY · Firm: JOHN LAMPMANN
H.R. 1778, H.R. 6344
To amend title 35, United States Code, to allow the Director of the United States Patent and Trademark Office to accept late filings in certain cases of unintentional delay.
Client: MEDICINES COMPANY · Firm: JOHN LAMPMANN
H.R. 1778
H.R. 1778, H.R. 6344
H.R. 1778, H.R. 6643
To amend title 35, United States Code, to allow the Director of the United States Patent and Trademark Office to accept late filings in certain cases of unintentional delay.
Client: MEDICINES COMPANY · Firm: JOHN LAMPMANN
H.R. 1778
H.R. 1778
Filing targets: HOUSE OF REPRESENTATIVES
MEDICINES COMPANY via JOHN LAMPMANN
2010 · second_quarter · Q2
H.R. 1778
Filing targets: HOUSE OF REPRESENTATIVES
MEDICINES COMPANY via JOHN LAMPMANN
2010 · first_quarter · Q1
H.R. 1778
Filing targets: HOUSE OF REPRESENTATIVES
MEDICINES COMPANY via JOHN LAMPMANN
2009 · fourth_quarter · Q4
H.R. 1778
Filing targets: HOUSE OF REPRESENTATIVES
RECORDING INDUSTRY ASSOCIATION OF AMERICA (RIAA) via JOHN LAMPMANN
2009 · fourth_quarter · 4T
Consultant on performance rights.
Filing targets: HOUSE OF REPRESENTATIVES
MEDICINES COMPANY via JOHN LAMPMANN
2009 · third_quarter · Q3
H.R. 1778
Filing targets: HOUSE OF REPRESENTATIVES
RECORDING INDUSTRY ASSOCIATION OF AMERICA (RIAA) via JOHN LAMPMANN
2009 · third_quarter · Q3
Consultant on performance rights.
Filing targets: HOUSE OF REPRESENTATIVES
RECORDING INDUSTRY ASSOCIATION OF AMERICA (RIAA) via JOHN LAMPMANN
2009 · second_quarter · Q2
Consultant on performance rights.
Filing targets: HOUSE OF REPRESENTATIVES
RECORDING INDUSTRY ASSOCIATION OF AMERICA (RIAA) via JOHN LAMPMANN
2009 · second_quarter · Q2
Consultant on performance rights.
Filing targets: HOUSE OF REPRESENTATIVES
MEDICINES COMPANY via JOHN LAMPMANN
2009 · second_quarter · Q2
H.R. 1778
Filing targets: HOUSE OF REPRESENTATIVES
RECORDING INDUSTRY ASSOCIATION OF AMERICA (RIAA) via JOHN LAMPMANN
2009 · second_quarter · RR
Consultant on performance rights.
MEDICINES COMPANY via JOHN LAMPMANN
2009 · first_quarter · Q1
H.R. 1778
Filing targets: HOUSE OF REPRESENTATIVES
MEDICINES COMPANY via JOHN LAMPMANN
2009 · first_quarter · Q1
H.R. 1778
Filing targets: HOUSE OF REPRESENTATIVES
MEDICINES COMPANY via JOHN LAMPMANN
2008 · fourth_quarter · Q4
H.R. 1778
Filing targets: HOUSE OF REPRESENTATIVES
MEDICINES COMPANY via JOHN LAMPMANN
2008 · third_quarter · Q3
H.R. 1778, H.R. 6344
Filing targets: HOUSE OF REPRESENTATIVES
MEDICINES COMPANY via JOHN LAMPMANN
2008 · second_quarter · Q2
H.R. 1778, H.R. 6643
Filing targets: HOUSE OF REPRESENTATIVES
MEDICINES COMPANY via JOHN LAMPMANN
2007 · year_end · YY
H.R. 1778
MEDICINES COMPANY via JOHN LAMPMANN
2007 · year_end · RR